Name: Mineralys Therapeutics, Inc. (MLYS) Balance Sheet
Creator: FinSpry

Mineralys Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Mineralys Therapeutics, Inc. (MLYS) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	114.09	49.30	87.70	10.61	1.41
Short-Term Investments	84.10	187.26	22.41	0.00	0.00
Cash & Short-Term Investments	198.19	236.57	110.11	10.61	1.41
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	7.16	12.54	2.70	0.46	0.06
Total Current Assets	205.35	249.10	112.81	11.12	1.47
Non-Current Assets
Property, Plant & Equipment (Net)	0.05	0.00	0.00	0.00	0.00
Long-Term Investments	0.00	2.48	0.00	0.00	0.00
Other Non-Current Assets	0.10	0.05	0.03	0.00	0.02
Total Non-Current Assets	0.55	2.53	1.63	0.00	0.00
Total Assets	205.90	251.64	114.44	11.13	1.49
Current Liabilities
Accounts Payable	0.48	0.60	1.91	0.76	0.53
Accrued Liabilities	14.17	9.88	5.50	4.29	0.05
Other Current Liabilities	14.17	0.00	0.00	0.00	0.00
Total Current Liabilities	14.65	10.48	8.07	5.05	5.08
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	158.64	29.00	0.00
Total Liabilities	14.65	10.48	166.71	5.05	5.08
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.00	0.01
Retained Earnings	-302.52	-124.71	-52.81	-23.01	-3.60
Additional Paid-in Capital	493.77	365.86	0.54	0.09	0.00
Shares Outstanding	49.82	41.13	39.06	39.06	0.00
Total Stockholders' Equity	191.26	241.15	-52.27	6.07	-3.60
Total Liabilities & Equity	205.90	251.64	114.44	11.13	0.00